Oral pharmacologic doses of cobalamin may not be as effective as parenteral cobalamin therapy in reversing hyperhomocystinemia and methylmalonic acidemia in apparently normal subjects

Clinical and Laboratory Haematology

Volumn 28, Issue 4, 2006, Pages 275-278

  Solomon, L R ^a  

^a YALE UNIVERSITY SCHOOL OF MEDICINE   (United States)

Author keywords

Cobalamin; Homocysteine; Methylmalonic acid

Indexed keywords

COBALAMIN; FOLIC ACID; HOMOCYSTEINE; METHYLENETETRAHYDROFOLATE REDUCTASE (NADPH2); METHYLMALONIC ACID; PYRIDOXINE; VITAMIN B GROUP;

ADULT; ARTICLE; CASE REPORT; CONTROLLED STUDY; CORRELATION ANALYSIS; DRUG BLOOD LEVEL; DRUG MECHANISM; FEMALE; FOLIC ACID BLOOD LEVEL; HETEROZYGOSITY; HORMONE SUBSTITUTION; HUMAN; HYPERHOMOCYSTEINEMIA; METABOLITE; METHYLMALONIC ACIDEMIA; POSTMENOPAUSE; PRIORITY JOURNAL; THROMBOPHILIA;

ADMINISTRATION, ORAL; FEMALE; HUMANS; HYPERHOMOCYSTEINEMIA; INJECTIONS, INTRAMUSCULAR; METHYLENETETRAHYDROFOLATE REDUCTASE (NADPH2); METHYLMALONIC ACID; MIDDLE AGED; VITAMIN B 12; VITAMIN B COMPLEX;

EID: 33746326101     PISSN: 01419854     EISSN: 13652257     Source Type: Journal    
DOI: 10.1111/j.1365-2257.2006.00783.x     Document Type: Article

References (15)

1. Berliner N. & Rosenberg L.E. (1981) Uptake and metabolism of free cyano-coboalamin by cultured human fibroblasts from controls and a patient with transcobalamin II deficiency. Metabolism 30, 230-236.
2. Blanche P., Si-Larbe A.-G. & Jouve P. (2001) Femoral head necrosis and hyperhomocysteinemia. Journal of Rheumatology 28, 1469.
3. Brown C.A., McKinney K.Q., Young K.B. & Norton H.J. (1999) The C677T methylenetetahydofolate reductase polymorphism influences the homocysteine-lowering effect of hormone replacement therapy. Molecular Genetics and Metabolism 67, 43-48.
4. Carmel R. (2000) Current concepts in cobalamin deficiency. Annual Review of Medicine 51, 357-375.
5. Chango A., Boisson F., Barbe F., Quilliot D., Droesch S., Pfister M., Fillon-Emery N., Lazbert D., Fremont S., Rosenblatt D.S. & Nicolas J.P. (2000) The effect of 677C-T and 1298 A-C mutationson plasma homocysteine and 5,10 methylene tetrahydrofolate reductase activity in healthy subjects. The British Journal of Nutrition 83, 593-596.
6. Coringe A., Ellis R., McDowell I., Vidal-Alaball J., Jenkins C., Butler C. & Worwood M. (2006) The value of methylmalonic acid, homocysteine and holotranscobalamin in the diagnosis of early B12 deficiency. Haematologica 91, 231-234.
7. Fowler B. (1998) Genetic defects of folate and cobalamin metabolism. European Journal of Pediatrics 157(Suppl. 2), S60-66.
8. Gulati S., Brody L.C. & Banerjee R. (1999) Posttranscriptional regulation of mammalian methionine synthase by B12. Biochemical and Biophysical Research Communications 259, 436-442.
9. Hoffer L.J. & Elian K.M. (2004) Parenteral vitamin B12 therapy of hyperhomocysteinemia in end-stage renal disease. Clinical and Investigative Medicine 24, 10-13.
10. Kuziminkski A.M., Del Giacco E.J., Allen R.H., Stabler S.P. & Lindenbaum J. (1998) Effective treatment of cobalamin deficiency with oral cobalamin. Blood 92, 1191-1198.
11. Miller J.W., Ramos M.I., Garrod M.G., Flynn M.A. & Green R. (2002) Transcobalamin II 775G > C polymorphism and indices of vitamin B12 status in healthy older adults. Blood 100, 718-720.
12. Qureshi A.A., Rosenblatt D.S. & Cooper B.A. (1994) Inherited disorders of cobalamin metabolism. Critical Reviews in Oncology/Hematology 17, 133-151.
13. Refsum H., Smith A.D., Ueland P.M., Nexo E., Clarke R., McPartlin J., Johnston C., Engbaek F., Schneede J., McPartlin C. & Scott J.M. (2004) Facts and recommendations about total homocysteine determinations: an expert opinion. Clinical Chemistry 50, 3-32.
14. Solomon L.R. (2005) Cobalamin-responsive disorders in the ambulatory care setting: unreliability of cobalamin, methyl-malonic acid and homocysteine testing. Blood 105, 978-985.
15. Solomon L.R. (2006) Disorders of cobalamin (vitamin B12) metabolism: emerging concepts in pathophysiology, diagnosis and treatment. Blood Reviews (in press).